Dr. Øystein Åmellem

Thermo Fisher Scientific


  • Head of Cell Therapy R&D and business unit in Thermo Fisher Scientific (2011 – )
  • 18 years’ experience for Thermo Fisher from different leadership positions in R&D and Business, responsible for development and commercialization of products and services for the Life Science and the Cell Therapy markets.


  • PhD in molecular cell biology, University of Oslo (1997)
  • Research fellow for Norsk Hydro AS, developing novel cancer drugs (1990-1997)
  • Post doc at Oslo University Hospital, studying physiological & molecular mechanisms of tumor cell growth (1997-2000)

other speakers